XY Therapeutics ApS — Credit Rating and Financial Key Figures

CVR number: 41120681
Rosenstandsvej 17 A, 2920 Charlottenlund

Income statement (kDKK)

2020
2021
2022
2023
Fiscal period length12121212
Net sales
Gross profit153.00627.00362.002 680.63
Employee benefit expenses- 244.00- 398.00- 475.00- 450.39
Other operating expenses-2 783.00-2 648.00- 518.00-3 262.06
EBIT-2 874.00-2 419.00- 631.00-1 031.83
Other financial income1.000.63
Other financial expenses- 269.00- 548.00- 636.00- 798.63
Pre-tax profit-3 143.00-2 967.00-1 266.00-1 829.83
Income taxes612.00583.00114.00459.97
Net earnings-2 531.00-2 384.00-1 152.00-1 369.85

Assets (kDKK)

2020
2021
2022
2023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current amounts owed by group member comp.0.55
Current other receivables620.001 222.00697.00574.03
Short term receivables total620.001 222.00697.00574.58
Cash and bank deposits6 616.004 126.004 195.004 324.15
Cash and cash equivalents6 616.004 126.004 195.004 324.15
Balance sheet total (assets)7 236.005 348.004 892.004 898.73

Equity and liabilities (kDKK)

2020
2021
2022
2023
Share capital40.0040.0040.0040.00
Retained earnings-2 532.00-4 916.00-6 067.79
Profit of the financial year-2 531.00-2 384.00-1 152.00-1 369.85
Shareholders equity total-2 491.00-4 876.00-6 028.00-7 397.65
Non-current other liabilities9 657.00
Non-current deferred tax liabilities10 142.0010 764.008 377.74
Non-current liabilities total9 657.0010 142.0010 764.008 377.74
Current loans from credit institutions3 185.20
Current trade creditors1.0068.00144.90
Other non-interest bearing current liabilities70.0081.0088.00588.53
Current liabilities total70.0082.00156.003 918.63
Balance sheet total (liabilities)7 236.005 348.004 892.004 898.73
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.